These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37096009)

  • 1. The safety of botulinum neurotoxin type A's intraarticular application in experimental animals.
    Okroša AD; Muñoz-Lora VRM; Matak I; Bach-Rojecky L; Kalinichev M; Lacković Z
    Toxicon X; 2023 Jun; 18():100155. PubMed ID: 37096009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison.
    Cruz F; Danchenko N; Fahrbach K; Freitag A; Tarpey J; Whalen J
    J Med Econ; 2023; 26(1):200-207. PubMed ID: 36647624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
    Danchenko N; Johnston KM; Whalen J
    J Med Econ; 2022; 25(1):919-929. PubMed ID: 35730362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
    Wu Y; Fang F; Lai W; Li C; Li L; Liu Q; Lu J; Pang X; Sun J; Shi X; Picaut P; Prygova I; Andriopoulos B; Sun Q
    Aesthetic Plast Surg; 2023 Feb; 47(1):351-364. PubMed ID: 36536093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive Actions of Botulinum Toxin A1 on Immunogenic Hypersensitivity in Temporomandibular Joint of Rats.
    Muñoz-Lora VRM; Dugonjić Okroša A; Matak I; Del Bel Cury AA; Kalinichev M; Lacković Z
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.
    Misra VP; Danchenko N; Maisonobe P; Lundkvist J; Hunger M
    J Clin Mov Disord; 2020; 7():2. PubMed ID: 32071728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral analgesic effects of abobotulinumtoxinA (Dysport
    Favre-Guilmard C; Chabrier PE; Kalinichev M
    Eur J Pain; 2017 May; 21(5):927-937. PubMed ID: 28263010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus.
    Cornet S; Périer C; Kalinichev M
    Toxicon X; 2020 Jun; 6():100029. PubMed ID: 32550584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence on botulinum toxin in selected disorders.
    Zakin E; Simpson D
    Toxicon; 2018 Jun; 147():134-140. PubMed ID: 29408357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluation.
    Danchenko N; Johnston KM; Haeussler K; Whalen J
    J Med Econ; 2021; 24(1):949-961. PubMed ID: 34340647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AbobotulinumtoxinA (Dysport
    Field M; Splevins A; Picaut P; van der Schans M; Langenberg J; Noort D; Snyder D; Foster K
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AbobotulinumtoxinA improves skin properties and sebum quality in the rhino mouse.
    Maignel J; Albinet V; Chusseau M; Lacoste E
    Toxicon; 2023 Sep; 233():107230. PubMed ID: 37517594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for facial wrinkles.
    Camargo CP; Xia J; Costa CS; Gemperli R; Tatini MD; Bulsara MK; Riera R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011301. PubMed ID: 34224576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA.
    Kutschenko A; Manig A; Reinert MC; Mönnich A; Liebetanz D
    Neurosci Lett; 2016 Aug; 627():216-21. PubMed ID: 27268041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
    Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
    Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.
    Rekand T; Biering-Sörensen B; He J; Vilholm OJ; Christensen PB; Ulfarsson T; Belusa R; Ström T; Myrenfors P; Maisonobe P; Dalager T
    BMJ Open; 2019 May; 9(5):e024340. PubMed ID: 31061021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Simpson DM; Hallett M; Ashman EJ; Comella CL; Green MW; Gronseth GS; Armstrong MJ; Gloss D; Potrebic S; Jankovic J; Karp BP; Naumann M; So YT; Yablon SA
    Neurology; 2016 May; 86(19):1818-26. PubMed ID: 27164716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
    Cai BB; Francis J; Brin MF; Broide RS
    Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
    Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
    Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis.
    Guyot P; Kalyvas C; Mamane C; Danchenko N
    J Child Neurol; 2019 Jun; 34(7):371-381. PubMed ID: 30803305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.